Securisyn Medical
Highlands Ranch, US · Colorado LLC
Securisyn develops endotracheal securement devices, including its flagship SolidAIRity Flex device for adults and a planned pediatric version. The company's products are medical devices not yet available for sale, with a planned U.S. launch in 2026.
HardwareHealthtechMedical Devices
Founders & leadership
EB
Elyse BlazevichDirector
MB
Mark BruningExecutive Officer, Director
AK
ARTHUR KANOWITZManager, Chairman, and Chief Medical Officer
BD
Bruno DarreDirector
TN
Troy NoemDirector
Competitors · 5
by search overlapDiabetes Prevention Program19 shared keywords
Cleveland Clinic, 202217 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Healthline17 shared keywordsHealthline publishes medically reviewed health and wellness content for general consumers, drawing on a network of medical reviewers. It operates as a consumer health media and information platform.
Dervan et al14 shared keywords
ResearchGate10 shared keywords
Companies competing with Securisyn Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$5.6MraisedAug 2025 · 30 investors · Other Health CareRule 506(b)
▶$5.6MraisedAug 2025 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruno DarreDirector
- Elyse BlazevichDirector
- Troy NoemDirector
- Mark BruningExecutive Officer, Director
- Offering amount
- $5.9M
- Amount sold
- $5.6M
- Minimum investment
- $5K
- First sale
- Aug 2025
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$1.9MraisedMar 2022 · 16 investors · Other Health CareRule 506(b)
▶$1.9MraisedMar 2022 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Troy NoemDirector
- Bernard DarrePromoter
- Alan GreenExecutive Officer
- Patrick HoweExecutive Officer
- Nam TrinhExecutive Officer
- Mark BruningExecutive Officer, Director, Promoter
- Arthur KanowitzExecutive Officer, Director, Promoter
- Elyse BlazevichDirector, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Jun 2021
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$150KraisedMar 2021 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedMar 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arthur KanowitzExecutive Officer, Director, Promoter
- Elyse BlazevichExecutive Officer, Director, Promoter
- Mark BruningExecutive Officer, Director, Promoter
- Bernard DarrePromoter
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$3.1MraisedSep 2020 · 40 investors · Other Health CareRule 506(b)
▶$3.1MraisedSep 2020 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark BruningExecutive Officer, Director, Promoter
- Arthur KanowitzExecutive Officer, Director, Promoter
- Bernard DarrePromoter
- Elyse BlazevichExecutive Officer, Director, Promoter
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Minimum investment
- $12.5K
- Proceeds to insiders
- $490K
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$6MraisedMar 2019 · 103 investors · Other Health CareRule 506(b)
▶$6MraisedMar 2019 · 103 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ELYSE BLAZEVICHExecutive Officer, Director, Promoter
- ARTHUR KANOWITZExecutive Officer, Director, Promoter
- Mark BruningExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $6M
- Minimum investment
- $25K
- Proceeds to insiders
- $900K
- First sale
- Feb 2011
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2020 | $750K |
| U.S. Air ForceAir Force | Phase II | 2020 | $750K |
| U.S. Air ForceAir Force | Phase I | 2019 | $158K |
| U.S. Air ForceAir Force | Phase I | 2019 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.